Skip to main content

Advertisement

SpringerLink
Log in

Pathological findings in enucleated eyes after intravitreal melphalan injection

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

The aim of this study is to evaluate the pathological findings of the eye after intravitreal melphalan for viable vitreous seeding from retinoblastoma. All enucleated eyes receiving an intravitreal injection of melphalan (10−50 μg in 0.05 cc) were evaluated for histological changes. Of 25 treated cases, 8 eyes needed enucleation because of phthisis, parent request, or new tumor development. One of the cases was excluded from the study because of a history of intra-arterial chemotherapy with melphalan. There was no case of needle-site scleral involvement by retinoblastoma cells. In two eyes receiving 50 μg melphalan, no viable retinoblastoma cell was detectable in the eye. Severe gliosis, vascular occlusion, retinal necrosis, hemorrhage and neovascularization were seen. Histologically, intravitreal melphalan for recalcitrant or recurrent vitreous seeds from retinoblastoma appears to provide acceptable vitreous seed control. It seems that higher doses could be destructive causing ischemic necrosis in the retina, severe gliosis and secondary neovascular changes as well as having a destructive effect on retinoblastoma cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA (2006) The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 113:2276–2280

    Article  PubMed  Google Scholar 

  2. Abramson DH, Ellsthworth RM, Tretter P, Adams K, Kitchin FD (1981) Simultaneous bilateral radiation for advanced bilateral retinoblastoma. Arch Ophthalmol 99:1763–1766

    Article  CAS  PubMed  Google Scholar 

  3. Shields CL, Shields JA, De Potter P, Minelli S, Hernandez C, Brady LW, Cater JR (1993) Plaque radiotherapy in the management of retinoblastoma. Ophthalmology 100:216–224

    Article  CAS  PubMed  Google Scholar 

  4. Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Rosenwasser R, Shields JA (2011) Intra-arterial chemotherapy for retinoblastoma. Report no. 1: control of tumor, subretinal seeds, and vitreous seeds. Arch Ophthalmol 129:1399–1406

    Article  PubMed  Google Scholar 

  5. Wilson MW, Qaddoumi I, Billups C, Haik BG, Rodriguez-Galindo C (2011) A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma. Br J Ophthalmol 95:553–558

    Article  PubMed  Google Scholar 

  6. Ericson LA, Rosengren BH (1961) Present therapeutic resources in retinoblastoma. Acta Ophthalmol 39:569–576

    Article  CAS  Google Scholar 

  7. Kaneko A (1996) Teach us about the current treatments of retinoblastoma. Atarashii Ganka 13:229–233 (in Japanese)

    Google Scholar 

  8. Kivelä T, Eskelin S, Paloheimo M (2011) Intravitreal methotrexate for retinoblastoma. Ophthalmology 118:1689

    Article  PubMed  Google Scholar 

  9. Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, Beck-Popovic M (2012) Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol 96:1078–1083

    Article  PubMed  Google Scholar 

  10. Ghassemi F, Shields CL (2012) Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch Ophthalmol 130:1268–1271

    Article  PubMed  Google Scholar 

  11. Bosaleh A, Sampor C, Solernou V, Fandiño A, Domínguez J, de Dávila MT, Chantada GL (2012) Outcome of children with retinoblastoma and isolated choroidal invasion. Arch Ophthalmol 130:724–729

    Article  PubMed  Google Scholar 

  12. Ericson LA, Kalberg B, Rosengren BH (1964) Trials of intravitreal injections of chemotherapeutic agents in rabbits. Acta Ophthalmol 42:721–726

    Article  CAS  Google Scholar 

  13. Inomata M, Kaneko A (1987) Chemosensitivity profiles of primary and cultured retinoblastoma cells in a human tumor clonogenic assay. Jpn J Cancer Res 78:858–868

    CAS  PubMed  Google Scholar 

  14. Ueda M, Tanabe J, Inomata M, Kaneko A, Kimura T (1995) Study on conservative treatment of retinoblastoma—effect of intravitreal injection of melphalan on the rabbit retina. J Jpn Ophthalmol Soc 99:1230–1235 (in Japanese)

    CAS  Google Scholar 

  15. Steinle JJ, Zhang Q, Thompson KE, Toutounchian J, Yates CR, Soderland C, Wang F, Stewart CF, Haik BG, Williams JS, Jackson JS, Mandrell TD, Johnson D, Wilson MW (2012) Intra-ophthalmic artery chemotherapy triggers vascular toxicity through endothelial cell inflammation and leukostasis. Invest Ophthalmol Vis Sci 30(53):2439–2445

    Article  Google Scholar 

  16. Eagle RC Jr, Shields CL, Bianciotto C, Jabbour P, Shields JA (2011) Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol 129:1416–1421

    Article  PubMed  Google Scholar 

  17. Kim J, Do H, Egbert P (2011) Enucleated eyes after failed intra-arterial infusion of chemotherapy for unilateral retinoblastoma: histopathologic evaluation of vitreous seeding. Clin Ophthalmol 5:1655–1658

    Article  PubMed Central  PubMed  Google Scholar 

  18. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP (2008) A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 115:1398–1404

    Article  PubMed  Google Scholar 

  19. Vajzovic LM, Murray TG, Aziz-Sultan MA, Schefler AC, Fernandes CE, Wolfe SC, Hess DJ, Dubovy SR (2010) Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Arch Ophthalmol 128:1619–1623

    Article  PubMed  Google Scholar 

  20. Graeber CP, Gobin YP, Marr BP, Dunkel IJ, Brodie SE, Bornfeld N, Char DH, Folberg R, Imhof SM, Lin AY, Berry JL, Al Mesfer S, Moll AC, Abramson DH (2011) Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastoma. Open Ophthalmol J 5:1–5

    Article  PubMed Central  PubMed  Google Scholar 

  21. Bechrakis NE, Bornfeld N, Schueler A, Coupland SE, Henze G, Foerster MH (1998) Clinicopathologic features of retinoblastoma after primary chemoreduction. Arch Ophthalmol 116:887–893

    Article  CAS  PubMed  Google Scholar 

  22. Dithmar S, Aabert TM Jr, Grossniklaus HE (2000) Histopathologic changes in retinoblastoma after chemoreduction. Retina 20:33–36

    Article  CAS  PubMed  Google Scholar 

  23. Demirci H, Eagle RC Jr, Shields CL, Shields JA (2003) Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Arch Ophthalmol 121:1125–1131

    Article  PubMed  Google Scholar 

  24. Munier FL, Beck-Popovic M, Balmer A, Gaillard MC, Bovey E, Binaghi S (2011) Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Retina 31:566–573

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

No conflict of interest.

Author information

Authors and Affiliations

  1. Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Qazvin Square, South Kargar, 1336616351, Tehran, Islamic Republic of Iran

    Fariba Ghassemi & Fahimeh Asadi Amoli

Authors
  1. Fariba Ghassemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fahimeh Asadi Amoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fariba Ghassemi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghassemi, F., Amoli, F.A. Pathological findings in enucleated eyes after intravitreal melphalan injection. Int Ophthalmol 34, 533–540 (2014). https://doi.org/10.1007/s10792-013-9851-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-013-9851-2

Keywords

Search

Navigation